These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28567555)

  • 21. Remission and Low Disease Activity Status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American Lupus Cohort (GLADEL).
    Ugarte-Gil MF; Wojdyla D; Pons-Estel GJ; Catoggio LJ; Drenkard C; Sarano J; Berbotto GA; Borba EF; Sato EI; Tavares Brenol JC; Uribe O; Ramirez Gómez LA; Guibert-Toledano M; Massardo L; Cardiel MH; Silveira LH; Chacón-Diaz R; Alarcón GS; Pons-Estel BA;
    Ann Rheum Dis; 2017 Dec; 76(12):2071-2074. PubMed ID: 28939626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of the utility of visual feedback in the treatment of early rheumatoid arthritis patients: a pilot study.
    El Miedany Y; El Gaafary M; Palmer D
    Rheumatol Int; 2012 Oct; 32(10):3061-8. PubMed ID: 21909946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.
    Mok CC; Ho LY; Cheung MY; Yu KL; To CH
    Scand J Rheumatol; 2009; 38(2):121-7. PubMed ID: 18991189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cigarette smoking and disease activity in systemic lupus erythematosus.
    Ghaussy NO; Sibbitt W; Bankhurst AD; Qualls CR
    J Rheumatol; 2003 Jun; 30(6):1215-21. PubMed ID: 12784392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic high-dose glucocorticoid therapy triggers the development of chronic organ damage and worsens disease outcome in systemic lupus erythematosus.
    Tarr T; Papp G; Nagy N; Cserép E; Zeher M
    Clin Rheumatol; 2017 Feb; 36(2):327-333. PubMed ID: 27889859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The early protective effect of hydroxychloroquine on the risk of cumulative damage in patients with systemic lupus erythematosus.
    Akhavan PS; Su J; Lou W; Gladman DD; Urowitz MB; Fortin PR
    J Rheumatol; 2013 Jun; 40(6):831-41. PubMed ID: 23588942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SLICC/ACR Damage Index in Afro-Caribbean patients with systemic lupus erythematosus: changes in and relationship to disease activity, corticosteroid therapy, and prognosis.
    Nossent JC
    J Rheumatol; 1998 Apr; 25(4):654-9. PubMed ID: 9558165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of Organ Damage Progression and Effect on Health-related Quality of Life in Systemic Lupus Erythematosus.
    Legge A; Doucette S; Hanly JG
    J Rheumatol; 2016 Jun; 43(6):1050-6. PubMed ID: 27084911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome measures to be used in clinical trials in systemic lupus erythematosus.
    Strand V; Gladman D; Isenberg D; Petri M; Smolen J; Tugwell P
    J Rheumatol; 1999 Feb; 26(2):490-7. PubMed ID: 9972993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe vitamin D deficiency increases the risk for moderate to severe disease activity in Chinese patients with SLE.
    Gao CC; Liu SY; Wu ZZ; Li TF; Gao GM; Liu ZS; Zheng ZH
    Lupus; 2016 Oct; 25(11):1224-9. PubMed ID: 26921268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison.
    Gladman DD; Goldsmith CH; Urowitz MB; Bacon P; Fortin P; Ginzler E; Gordon C; Hanly JG; Isenberg DA; Petri M; Nived O; Snaith M; Sturfelt G
    J Rheumatol; 2000 Feb; 27(2):373-6. PubMed ID: 10685799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydroxychloroquine Serum Concentrations and Flares of Systemic Lupus Erythematosus: A Longitudinal Cohort Analysis.
    Mok CC; Penn HJ; Chan KL; Tse SM; Langman LJ; Jannetto PJ
    Arthritis Care Res (Hoboken); 2016 Sep; 68(9):1295-302. PubMed ID: 26749299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Classification of Systemic Lupus Erythematosus: Systemic Lupus International Collaborating Clinics Versus American College of Rheumatology Criteria. A Comparative Study of 2,055 Patients From a Real-Life, International Systemic Lupus Erythematosus Cohort.
    Inês L; Silva C; Galindo M; López-Longo FJ; Terroso G; Romão VC; Rúa-Figueroa I; Santos MJ; Pego-Reigosa JM; Nero P; Cerqueira M; Duarte C; Miranda LC; Bernardes M; Gonçalves MJ; Mouriño-Rodriguez C; Araújo F; Raposo A; Barcelos A; Couto M; Abreu P; Otón-Sanchez T; Macieira C; Ramos F; Branco JC; Silva JA; Canhão H; Calvo-Alén J; ;
    Arthritis Care Res (Hoboken); 2015 Aug; 67(8):1180-5. PubMed ID: 25581417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Joint ultrasound baseline abnormalities predict a specific long-term clinical outcome in systemic lupus erythematosus patients.
    Corzo P; Salman-Monte TC; Torrente-Segarra V; Polino L; Mojal S; Carbonell-Abelló J
    Lupus; 2017 Jun; 26(7):729-733. PubMed ID: 27837195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measuring therapeutic adherence in systemic lupus erythematosus with electronic monitoring.
    Marengo MF; Waimann CA; de Achaval S; Zhang H; Garcia-Gonzalez A; Richardson MN; Reveille JD; Suarez-Almazor ME
    Lupus; 2012 Oct; 21(11):1158-65. PubMed ID: 22588588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the relationship between disease activity and damage in patients with systemic lupus erythematosus--a 5-yr prospective study.
    Stoll T; Sutcliffe N; Mach J; Klaghofer R; Isenberg DA
    Rheumatology (Oxford); 2004 Aug; 43(8):1039-44. PubMed ID: 15161983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropsychiatric systemic lupus erythematosus: association with global disease activity.
    Morrison E; Carpentier S; Shaw E; Doucette S; Hanly JG
    Lupus; 2014 Apr; 23(4):370-7. PubMed ID: 24457602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care.
    Castrejón I; Tani C; Jolly M; Huang A; Mosca M
    Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-85-95. PubMed ID: 25365095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Damage accrual in southern Chinese patients with systemic lupus erythematosus.
    Mok CC; Ho CT; Wong RW; Lau CS
    J Rheumatol; 2003 Jul; 30(7):1513-9. PubMed ID: 12858450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis.
    Ståhl-Hallengren C; Jönsen A; Nived O; Sturfelt G
    J Rheumatol; 2000 Mar; 27(3):685-91. PubMed ID: 10743809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.